Immuno 2026 Opens with Global Leaders Exploring the Next Decade of Cancer Immunotherapy
Sep 24, 2026
View online
Immuno 2026 Opens with Global Leaders Exploring the Next Decade of Cancer Immunotherapy
FDA Approved Lirafugratinib for FGFR2 Fusion or Rearrangement–Positive Cholangiocarcinoma
Global Cancer Leaders Gather in Brussels to Mark 10 Years of World Cancer Research Day
Bishal Gyawali: Why Access to Clinical Trials Is an Important Equity Metric
ZS Continues Partnership with OncoDaily for The State of Oncology in 2026
UK Approves Lurbinectedin Plus Atezolizumab as First-Line Maintenance Therapy for Small Cell Lung Cancer
WCC 2026 Highlights Growing Focus on Climate Change and the Future of Cancer Care
Cancer In US Media: 2026: Report
Learn More
NIH PRIMED-AI Validation Center 2026
Pancreatic Cancer Action Network Collaborative Catalyst Research Award 2027
Immuno 2026: Global Virtual Congress on Immuno Oncology
World Cancer Congress 2026
The Voice of Oncology
Unsubscribe
|
Manage subscription
OncoDaily, P53 Inc.
867 Boylston Street, 5th Floor, Suite 1094, Boston, MA 02116
Copyright (C) 2023-2026. OncoDaily, P53 Inc. All rights reserved.
